Cardiovascular Diseases

Blood Pressure Variability Linked to Dementia

A prospective cohort study of a general Japanese population demonstrated a significant independent association between increased day-to-day blood pressure variability (BPV) measured with home blood pressure monitoring and risk of dementia. The study included 1674 community-dwelling Japanese elderly without dementia, ≥60 years of age, and followed up for 5 years (2007–2012). Day-to-day BPV, calculated as coefficients of variation (CoV) of home blood pressure, were categorized into quartiles. During the follow-up, 194 subjects developed all-cause dementia; of these, 47 vascular dementia (VaD) and 134 had Alzheimer disease (AD). The age- and sex-adjusted incidences of all-cause dementia, VaD, and AD increased significantly with increasing CoV levels of home systolic blood pressure (SBP). Similar associations were observed for CoV levels of home diastolic blood pressure. Home SBP levels were significantly associated with the risk of VaD. BPV has been recognized as an independent risk factor for cardiovascular diseases. Source: http://circ.ahajournals.org/

hyangiu

Recent Posts

Global Study of Stroke Risk Factors

A study revealed that stroke remains a major global health challenge, influenced by numerous risk…

1 day ago

Antidepressants Effective and Safe in Older Adults with Anxiety

A systematic review and meta-analysis evaluated randomized controlled trials on pharmacological treatments for anxiety in…

2 days ago

Geographical Variation in Lipoprotein (a) Levels Among CHD Patients

A global study suggested that most patients with coronary heart disease (CHD) have Lipoprotein (a)…

2 weeks ago

The Science and Skepticism around Seed Oils

A recent article explored the science and skepticism surrounding seed oils. These oils—extracted from sources…

3 weeks ago

Bedtime Antihypertensive Comparable to Morning Use

A Canadian study of adults with high blood pressure (BP) found no difference in health…

4 weeks ago

Obicetrapib Effective and Safe in Improving Lipids

Two randomized, controlled trials evaluated the efficacy and safety of obicetrapib, an oral cholesteryl ester…

1 month ago

This website uses cookies.